Skip to Main content

Researcher identifiers

Number of documents

38

David MOULIN


Journal articles29 documents

  • Marie Maumus, Danièle Noël, Hang Korng Ea, David Moulin, Maxime Ruiz, et al.. Identification of TGFβ signatures in six murine models mimicking different osteoarthritis clinical phenotypes. Osteoarthritis and Cartilage, Elsevier, 2020, 28 (10), pp.1373-1384. ⟨10.1016/j.joca.2020.06.008⟩. ⟨hal-02899374⟩
  • Laura Polivka, Laurent Frenzel, Jean-Yves Jouzeau, Olivier Hermine, David Moulin. Mast cells in spondyloarthritis, more than simple inflammatory bystanders?. Therapeutic advances in musculoskeletal disease, Sage Publications, 2020, 12, pp.1759720X2097190. ⟨10.1177/1759720X20971907⟩. ⟨hal-03090864⟩
  • Tinhinane Fali, Tegest Aychek, Maroua Ferhat, Jean-Yves Jouzeau, Meinrad Busslinger, et al.. Metabolic regulation by PPARγ is required for IL-33-mediated activation of ILC2s in lung and adipose tissue. Mucosal Immunology, Nature Pub. Group, In press, ⟨10.1038/s41385-020-00351-w⟩. ⟨hal-03005537⟩
  • Julie Hablot, Maroua Ferhat, Aonghus Lavelle, Fatouma Salem, Mahdia Taieb, et al.. Tofacitinib treatment alters mucosal immunity and gut microbiota during experimental arthritis. Clinical and Translational Medicine, Heidelberg : Springer-Verlag, 2020, 10 (5), pp.e163. ⟨10.1002/ctm2.163⟩. ⟨hal-03005532⟩
  • Marine Fauny, David Moulin, Ferdinando D'amico, Patrick Netter, Nadine Petitpain, et al.. Paradoxical gastrointestinal effects of interleukin-17 blockers. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2020, 79 (9), pp.1132 - 1138. ⟨10.1136/annrheumdis-2020-217927⟩. ⟨hal-02920284⟩
  • Fatouma Salem, Nadège Kindt, Julian Marchesi, Patrick Netter, Anthony Lopez, et al.. Gut microbiome in Chronic Rheumatic and Inflammatory Bowel Diseases: similarities and differences. United European Gastroenterology Journal, SAGE Publications, In press, 7 (8), pp.1008-1032. ⟨10.1177/2050640619867555⟩. ⟨hal-02192635⟩
  • Chaohua Deng, Arnaud Bianchi, Nathalie Presle, David Moulin, Meriem Koufany, et al.. Eplerenone treatment alleviates the development of joint lesions in a new rat model of spontaneous metabolic-associated osteoarthritis. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (2), pp.315 - 316. ⟨10.1136/annrheumdis-2016-210700⟩. ⟨hal-01702028⟩
  • Tunay Kokten, Sébastien Gibot, Patricia Lepage, Silvia D 'Alessio, Julie Hablot, et al.. TREM-1 Inhibition Restores Impaired Autophagy Activity and Reduces Colitis in Mice. Journal of Crohn's and Colitis, Elsevier - Oxford University Press, 2018, 12 (2), pp.230-244. ⟨10.1093/ecco-jcc/jjx129⟩. ⟨hal-01715133⟩
  • Chaohua Deng, Arnaud Bianchi, Nathalie Presle, David Moulin, Meriem Koufany, et al.. Response to: ‘Spontaneous hypertensive rat exhibits bone and meniscus phenotypes of osteoarthritis: is it an appropriate control for MetS-associated OA?’ by Chan and Wen. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2018, 77 (5), pp.e26-e26. ⟨10.1136/annrheumdis-2017-212003⟩. ⟨hal-02983106⟩
  • Véronique Rolli, Cécile Macquin, Tunay Kokten, Julie Hablot, Ndeye-Coumba Ndiaye, et al.. Zinc-Alpha-2-Glycoprotein in Inflammatory Bowel Disease. Inflammatory Bowel Diseases, Lippincott, Williams & Wilkins, 2018, 24 (5), pp.e10. ⟨10.1093/ibd/izy120⟩. ⟨hal-02401061⟩
  • Anne Wilson, Mariano Schiffrin, Carine Winkler, Meriem Koufany, Jean-Yves Jouzeau, et al.. Lack of Adipocytes Alters Hematopoiesis in Lipodystrophic Mice. Frontiers in Immunology, Frontiers, 2018, 9, pp.2573. ⟨10.3389/fimmu.2018.02573⟩. ⟨hal-02401054⟩
  • Julie Hablot, Laurent Peyrin-Biroulet, Tunay Kokten, Reine Omar, Patrick Netter, et al.. Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice. PLoS ONE, Public Library of Science, 2017, 12 (9), pp.e0184624. ⟨10.1371/journal.pone.0184624⟩. ⟨hal-01618133⟩
  • Lieven Pouillon, Peter Bossuyt, Joke Vanderstukken, David Moulin, Patrick Netter, et al.. Management of patients with inflammatory bowel disease and spondyloarthritis. Expert Review of Clinical Pharmacology, Informa Plc, 2017, 10 (12), pp.1363-1374. ⟨10.1080/17512433.2017.1377609⟩. ⟨hal-01715137⟩
  • David Moulin, Veronique Salone, Meriem Koufany, Thomas Clément, Isabelle Behm-Ansmant, et al.. MicroRNA-29b Contributes to Collagens Imbalance in Human Osteoarthritic and Dedifferentiated Articular Chondrocytes. BioMed Research International , Hindawi Publishing Corporation, 2017, 2017, pp.1 - 12. ⟨10.1155/2017/9792512⟩. ⟨hal-01704545⟩
  • Ichraq Latar, Meriem Koufany, Julie Hablot, Damien Loeuille, Patrick Netter, et al.. Association between rheumatoid arthritis and systemic mastocytosis: a case report and literature review. Clinical Rheumatology, Springer Verlag, 2016, 35 (10), pp.2619-2623. ⟨10.1007/s10067-016-3368-9⟩. ⟨hal-01715226⟩
  • Mathieu Riffault, David Moulin, Laurent Grossin, Didier Mainard, Jacques Magdalou, et al.. Label-free relative quantification applied to LC-MALDI acquisition for rapid analysis of chondrocyte secretion modulation. Journal of Proteomics, Elsevier, 2015, 114, pp.263-273. ⟨10.1016/j.jprot.2014.10.026⟩. ⟨hal-01451913⟩
  • Arnaud Bianchi, D. Moulin, S. Hupont, M. Koufany, P. Netter, et al.. Oxidative stress-induced expression of HSP70 contributes to the inhibitory effect of 15d-PGJ(2) on inducible prostaglandin pathway in chondrocytes. Free Radical Biology and Medicine, Elsevier, 2014, 76, pp.114-126. ⟨10.1016/j.freeradbiomed.2014.07.028⟩. ⟨hal-01453217⟩
  • Meriem Koufany, Jean-Yves Jouzeau, David Moulin. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. Bio-Medical Materials and Engineering, IOS Press, 2014, 24 (1), pp.S81-S88. ⟨10.3233/BME-140977⟩. ⟨hal-01452704⟩
  • P. -J. Francin, Anne Abot, Cécile Guillaume, David Moulin, Arnaud Bianchi, et al.. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthritis and Cartilage, Elsevier, 2014, 22 (3), pp.519-526. ⟨10.1016/j.joca.2014.01.002⟩. ⟨hal-01452716⟩
  • Meriem Koufany, Daniel Chappard, Patrick Netter, Claire Bastien, Georges Weryha, et al.. The Peroxisome Proliferator-Activated Receptor gamma Agonist Pioglitazone Preserves Bone Microarchitecture in Experimental Arthritis by Reducing the Interleukin-17-Dependent Osteoclastogenic Pathway. Arthritis and Rheumatism, Wiley, 2013, 65 (12), pp.3084-3095. ⟨10.1002/art.38130⟩. ⟨hal-01464666⟩
  • Joseph Paquet, Jean-Christophe Goebel, Camille Delaunay, Astrid Pinzano, Laurent Grossin, et al.. Cytokines profiling by multiplex analysis in experimental arthritis: which pathophysiological relevance for articular versus systemic mediators? . Arthritis Research and Therapy, BioMed Central, 2012, 14 (2), pp.R60. ⟨10.1186/ar3774⟩. ⟨hal-01715286⟩
  • Jean-Yves Jouzeau, David Moulin, Meriem Koufany, Sylvie Sébillaud, Arnaud Bianchi, et al.. Pathophysiological relevance of peroxisome proliferators activated receptors (PPAR) to joint diseases – the pro and con of agonists. Journal- Societe de Biologie, Paris : Société de biologie, 2008, 202 (4), pp.289-312. ⟨10.1051/jbio:2008034⟩. ⟨hal-01715298⟩
  • Meriem Koufany, David Moulin, Arnaud Bianchi, Mikhaela Muresan, Sylvie Sébillaud, et al.. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Research and Therapy, BioMed Central, 2008, 10 (1), pp.R6. ⟨10.1186/ar2354⟩. ⟨hal-01715309⟩
  • David Moulin, Olivier Donzé, Dominique Talabot-Ayer, Françoise Mezin, Gaby Palmer, et al.. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells. Cytokine, Elsevier, 2007, 40 (3), pp.216-225. ⟨10.1016/j.cyto.2007.09.013⟩. ⟨hal-01715320⟩
  • Frederic Cailotto, Arnaud Bianchi, Sylvie Sébillaud, Narayanan Venkatesan, David Moulin, et al.. Inorganic pyrophosphate generation by transforming growth factor-beta-1 is mainly dependent on ANK induction by Ras/Raf-1/extracellular signal-regulated kinase pathways in chondrocytes. Arthritis Research and Therapy, BioMed Central, 2007, 9 (6), pp.R122. ⟨10.1186/ar2330⟩. ⟨hal-01704426⟩
  • David Moulin, Paul-Emile Poleni, Mélanie Kirchmeyer, Sylvie Sébillaud, Meriem Koufany, et al.. Effect of peroxisome proliferator activated receptor (PPAR)gamma agonists on prostaglandins cascade in joint cells.. Biorheology, IOS Press, 2006, 43, pp.561-75. ⟨hal-01715321⟩
  • David Moulin, Arnaud Bianchi, Sandrine Boyault, Sylvie Sébillaud, Meriem Koufany, et al.. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism. Arthritis and Rheumatism, Wiley, 2005, 52 (3), pp.759-769. ⟨10.1002/art.20868⟩. ⟨hal-01715364⟩
  • Arnaud Bianchi, David Moulin, Sylvie Sébillaud, Meriem Koufany, Marie-Madeleine Galteau, et al.. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)γ agonists on membrane-associated prostaglandin E 2 synthase-1 in IL-1β-stimulated rat chondrocytes: evidence for PPARγ-independent inhibition by 15-deoxy-∆ 12,14 prostaglandin J 2. Arthritis Research and Therapy, BioMed Central, 2005, 7 (6), pp.R1325-R1337. ⟨10.1186/ar1830⟩. ⟨hal-01715324⟩
  • Jean Claude Micillino, Catherine Coulais, Stéphane Binet, Marie Claire Bottin, Gerard Keith, et al.. Lack of genotoxicity of bitumen fumes in transgenic mouse lung.. Toxicology, Elsevier, 2002, 170 (1-2), pp.11-20. ⟨10.1016/S0300-483X(01)00507-8⟩. ⟨hal-01715374⟩

Conference papers4 documents

  • Julie Hablot, Jean-Yves Jouzeau, Meriem Koufany, Béatrice Desvergne, Gérard Eberl, et al.. Étude du microbiote intestinal et des cellules productrices d'IL-17 chez les souris arthritiques et lipo-atrophiques PPARγ déficientes : un modèle de désordre immunométabolique ? . 30ème Congrès Français de Rhumatologie (SFR), Dec 2017, Paris, France. pp.A139 (O.114). ⟨hal-01775264⟩
  • J. Hablot, M. Koufany, P. Reboul, J.-Y. Jouzeau, D. Moulin. FRI0017 Pharmacological Blockade of CCR3 Reduces Collagen-Induced Arthritis Severity. Annual European Congress of Rheumatology (EULAR), 2016, Londres, United Kingdom. pp.431.3 - 432, ⟨10.1136/annrheumdis-2016-eular.4069⟩. ⟨hal-01706984⟩
  • J. Hablot, Meriem Koufany, Jean-Yves Jouzeau, David Moulin. Pharmacological blockade of CCR3 improves collagen-induced arthritis. 20th Annual Meeting of French Society of Pharmacology and Therapeutics, 37th Pharmacovigilance Meeting, 17th APNET Seminar, 14th CHU CIC Meeting, Apr 2016, Nancy, France. pp.20-21, ⟨10.1111/fcp.12188⟩. ⟨hal-01513896⟩
  • Meriem Koufany, F. Gilardi, M. Schiffrin, C. Winkler, Arnaud Bianchi, et al.. PPAR gamma deficient mice develop spontaneous polyarthritis. EULAR 2014, Jun 2014, Paris, France. pp.128. ⟨hal-01514057⟩

Poster communications1 document

  • Arnaud Bianchi, David Moulin, Sebastien Hupont, Meriem Koufany, Patrick Netter, et al.. Expression of HSP70 by oxidative stress contributes to the inhibitory effect of 15d-PGJ2 on inducible prostaglandin pathway in chondrocyte. 10ème Congrès de la Société Française de Pharmacologie & Thérapeutique (SFP&T), Apr 2015, Caen, France. Fundamental and Clinical Pharmacology, 29 (Suppl 1), pp.31, 2015. ⟨hal-01775312⟩

Patents2 documents

  • Jean-Jacques Garaud, Marc Derive, Margarita Salcedo-Magguilli, Lucie Jolly, Sebastien Gibot, et al.. Soluble trem-1 as a marker of severity or complications for a subject suffering from a coronovirus infection. France, Patent n° : 20305604.9-1118. 2020. ⟨hal-03005511⟩
  • Anne Pizard, Chaohua Deng, Hervé Kempf, Arnaud Bianchi, David Moulin, et al.. Antagonist of mineralocorticoid receptor for the treatment of osteoarthritis. France, Patent n° : WO2018019843. 2018. ⟨hal-02950844⟩

Preprints, Working Papers, ...2 documents

  • Maria-Bernadette Madel, Lidia Ibanez, Thomas Ciucci, Julia Halper, Majlinda Topi, et al.. Osteoclasts contribute to early development of chronic inflammation by promoting dysregulated hematopoiesis and myeloid skewing. 2021. ⟨hal-03064977⟩
  • He Fu, Maria-Bernadette Madel, Dominique Pierroz, Mariano Schiffrin, Carine Winkler, et al.. Adipose-tissue derived signals control bone remodelling. 2020. ⟨hal-02873939⟩